Targeting androgen receptor for prostate cancer therapy: From small molecules to PROTACs | | 2022 |
Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort | | |
Metastatic Prostate Adenocarcinoma Presenting as Acute Quadriplegia: A Case Report and Racial Disparity Analysis | | 2022 |
Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment | | |
Disease Burden of Prostate Cancer from 2014 to 2019: Estimation from the Global Burden of Disease Study 2019 and Medical Expenditure Panel Survey. | | |
Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions | | 2022 |
Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT | | 2022 |
Should Contemporary Western Guidelines Based on Studies Conducted in the 2000s Be Adopted for the Prostate-Specific Antigen Screening Policy for Asian Men in the 2020s? | | |
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends | Clinical Drug Investigation | |
Detection of Circulating Glial Cells Enables Non-Invasive Diagnosis of Glial Malignancies | | |
Is docetaxel-free interval a predictive factor for castration-resistant prostate cancer? | Actas Urológicas Españolas (English Edition) | 2022 |
US Population Reference Values for Health-Related Quality of Life Questionnaires Based on Demographics of Patients with Prostate Cancer | Advances in Therapy | |
¿Es el intervalo libre de docetaxel un factor predictivo para el cáncer de próstata resistente a la castración? | Actas Urológicas Españolas | 2022 |
Primary Tumor Staging and Detection of Common Sites of Distant Metastatic Disease | | 2022 |
A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer | European Urology | 2022 |
Pathological Roles of Reactive Oxygen Species in Male Reproduction | Advances in Experimental Medicine and Biology | 2022 |
99mTc-PSMA SPECT in Prostate Cancer | Clinical and Translational Imaging | |
Accurate Prostate Cancer Detection based on Circulating Tumor Cell Profiling | | |
Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality. | JAMA Network Open | 2022 |
Lutetium Lu 177 Vipivotide Tetraxetan: First Approval. | Molecular Diagnosis and Therapy | 2022 |
Office-Based, Single-Sided, Low-Field MRI-Guided Prostate Biopsy | Cureus | 2022 |
Lower fracture rates in patients treated with Radium-223, abiraterone or enzalutamide, when given concurrently with bone health agents: A real world analysis | Clinical Genitourinary Cancer | 2022 |
A narrative review of biparametric MRI (bpMRI) implementation on screening, detection, and the overall accuracy for prostate cancer. | Therapeutic Advances in Urology | 2022 |
Racial/Ethnic Differences in Health-Related Quality of Life Among Gay and Bisexual Prostate Cancer Survivors. | Frontiers in Oncology | 2022 |
Evaluation of maintenance of the common androgen deprivation therapy with the new antiandrogen therapy in patients with castration-resistant prostate cancer: a systematic review. | International Urology and Nephrology | 2022 |
Focal prostate cancer therapy in the era of multiparametric MRI: a review of options and outcomes. | Prostate Cancer and Prostatic Diseases | 2022 |
Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients with Non-Metastatic Castration-Resistant Prostate Cancer. | Urology | 2022 |
PSA Testing in Men Receiving Testosterone Therapy with History of Prostate Cancer: A Matched Analysis of a Large Multi-Institutional Research Network. | Urology | 2022 |
Development of a novel castration-resistant orthotopic prostate cancer model in New Zealand White rabbit. | Prostate | 2022 |
Assessing the impact of decision aid use on post prostatectomy patient reported outcomes. | Urology | 2022 |
Development of a Sexual Quality of Life Questionnaire for Men-Who-Have-Sex-With-Men With Prostate Cancer. | Sexual Medicine | 2022 |
Re: NCCN Prostate Cancer Guidelines Version 1.2022 - September 10, 2021. | European Urology | 2021 |
Promoting informed prostate cancer screening decision-making for African American men in a community-based setting. | Cancer Causes and Control | 2022 |
Biomarkers in Urinary Tract and Male Genital System Carcinomas | | 2022 |
Population-based survival for cancer patients in Saudi Arabia for the years 2005-2009. | Scientific Reports | 2022 |
Examination of prostate-specific antigen (PSA) screening in military and civilian men: analysis of the 2018 behavioral risk factor surveillance system. | Cancer Causes and Control | 2022 |
Metastatic Prostate Adenocarcinoma: A Rare Presentation. | Cureus | 2022 |
Racial Differences in Prostate Cancer Characteristics and Cancer-Specific Mortality: An Overview. | World Journal of Men?s Health | 2022 |
El índice nutricional pronóstico como factor pronóstico independiente para la respuesta al tratamiento, la supervivencia y la elección del fármaco en el cáncer de próstata metastásico resistente a la castración tratado con acetato de abiraterona o enzalutamida | Actas Urológicas Españolas | 2021 |
Targeted Radionuclide Therapy and Immunotherapy of Metastatic Prostate Cancer | | 2022 |
Improved survival with post-diagnostic metformin and statin use in a racially diverse cohort of US Veterans with advanced prostate cancer | Prostate Cancer and Prostatic Diseases | 2021 |
Estimating the Financial Impact of Gene Therapy* | | |
Nutraceuticals and Wellness | | 2020 |
The Handbook of Wellness Medicine | | 2020 |
Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent | Frontiers in Oncology | 2021 |
A Jaw-Dropping Diagnosis | Journal of Hospital Medicine | 2020 |
Virtue Chapter | | 2020 |
ADC mapping with 12 b values: an improved technique for image quality in diffusion prostate MRI | | |
Comparative study between monoexponential and biexponential diffusion weighted imaging sequences in multiparametric prostate magnetic resonance imaging | Einstein (Sao Paulo, Brazil) | 2019 |
Transition from normal to cancerous cell by precancerous niche (PCN) induced chronic cell-matrix stress | 4open | 2019 |